WeHealth

What WeHealth does

WeHealth operates a patient-led clinical trial recruitment platform that connects pharmaceutical, biotech, and academic medical center sponsors with patients across rare and underserved disease communities. Founded by Will Raasch — a former FDA Office of Orphan Drug Products analyst and Baxter Healthcare rare disease manager — the company is headquartered in Los Angeles, California, and operates under the legal entity WEHEALTH CO. The patient-facing platform is free and supports 25,000+ users across at least 11 disease areas including Parkinson's Disease, Multiple Sclerosis, Gulf War Illness, Chronic Fatigue Syndrome (ME/CFS), GERD, Psoriasis, Kidney Disease, Wilson Disease, Lipodystrophy, Deafness, and Red Tide.

The platform combines an Adaptive Screener for condition-specific eligibility matching, a Patient Ambassador Network that drives trusted community referrals across SMS, social media, and email, a Precision Reach targeting system, symptom-based education campaigns to reach undiagnosed populations, and a Real-Time Analytics Dashboard providing 100% attribution visibility from awareness to enrollment. Supporting assets include a HIPAA-compliant privacy infrastructure, a WeHealth mobile application for iOS, and content resources such as case studies and white papers. Technology stack details, AI/ML models, and integrations are not disclosed in source materials.

The business model is B2B professional services: clinical trial sponsors engage WeHealth for custom-scoped recruitment campaigns quoted per engagement under multi-year contracts, while the patient-facing platform remains free. Go-to-market combines a community-led patient ambassador motion with consultative enterprise field sales targeting pharma, biotech, academic medical centers, and government sponsors such as the VA. Pricing is not publicly disclosed. The company is privately held, bootstrapped, and reports 1-10 employees with no disclosed venture funding.

Name

WeHealth

Legal name

WEHEALTH CO.

Website

https://wehealth.io

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

WeHealth is a privately held, bootstrapped health-tech company operating a patient-led clinical trial recruitment platform that connects pharma, biotech, academic, and government sponsors with rare and underserved disease communities through an ambassador-driven screening and matching platform.

Ownership category

akta.pro rank

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Clinical Trial Recruitment Services (B2B): WeHealth provides patient recruitment campaign services to clinical trial sponsors (pharma, biotech, academic medical centers). Services are scoped and quoted per engagement, with campaigns designed to accelerate enrollment for specific trials. The company charges sponsors for access to its patient ambassador network and campaign management platform. The patient-facing platform is free.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

WeHealth runs patient-led clinical trial recruitment campaigns for pharmaceutical, biotech, and academic research sponsors. Its platform combines an adaptive patient screener, a network of disease-specific patient ambassadors, and real-time attribution analytics to identify, pre-qualify, and refer eligible patients into clinical trials faster than traditional recruitment methods. The patient-facing platform (screeners, campaign pages, mobile app, and resource hubs for Parkinson's, MS, Gulf War Illness, ME/CFS, and other conditions) is free; sponsors pay custom-quoted fees for recruitment campaign engagements.

Product overview

WeHealth offers a patient-led clinical trial recruitment platform that combines disease-specific screeners, ambassador-driven advocacy campaigns, and enterprise analytics to accelerate enrollment 9X faster than traditional methods. The platform includes condition-specific campaign pages (Parkinson's Disease, Multiple Sclerosis, Gulf War Illness, Chronic Fatigue Syndrome, and others), an adaptive screener tool for patient eligibility matching, and a mobile application. Supporting resources include white papers on diversity and patient-centricity, and case studies demonstrating recruitment outcomes across rare and underserved disease populations.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Screener Platform Online adaptive assessment tool that matches patients with relevant clinical trials and health resources through condition-specific questionnaires, supporting self-identification and eligibility checking for clinical research.
• Campaign Platform (Patient-Led Recruitment Platform) Enterprise platform that enables advocacy campaigns for specific diseases, where patient ambassadors share recruitment resources with their networks to accelerate clinical trial enrollment through trusted community channels.
• Disease-Specific Recruitment Campaigns Targeted advocacy campaigns for specific conditions including Parkinson's Disease, Multiple Sclerosis, Gulf War Illness, Chronic Fatigue Syndrome (ME/CFS), GERD, Psoriasis, Kidney Disease, Wilson Disease, Lipodystrophy, Deafness, and Red Tide, each with dedicated screeners and resource hubs for clinical trial recruitment.
• WeHealth Mobile App iPhone and iPad application available via the Apple App Store that enables patients to access screeners, share campaigns, and connect with clinical trial opportunities on mobile devices.
• Genetic Testing Coordination Services Service supporting patients through at-home genetic kit ordering and clinical site scheduling, including patient coordinator conversations to build trust around genetic testing for rare disease trials such as LRRK2 Parkinson's.

Quantifiable outcome

• 9X faster patient enrollment vs. traditional methods (9X improvement in Chronic Fatigue trial recruitment rate; same randomized output as $776K digital ad spend for $74K in Parkinson's trial)
• +8 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Mount Sinai Hospital SystemcoreStrategic or Co-development PartnerWeHealth partnered with a major research center within the Mount Sinai Hospital system in New York City for a Gulf War Illness clinical trial. After the sponsor had enrolled only 20 patients in 2 years (25% of their goal) with a grant at risk of cancellation, WeHealth delivered 165 eligible veterans screened within 3 months through veteran community outreach, achieving a 60X improvement in monthly recruitment rate. This partnership is documented as a flagship case study demonstrating WeHealth's ability to recover failing recruitment campaigns.
• WRIISC (War Related Illness and Injury Study Center)coreStrategic or Co-development PartnerWRIISC, a VA center dedicated to evaluating veterans with deployment-related health concerns, partnered with WeHealth for Gulf War Illness recruitment. The WRIISC Director, Dr. Gudrun Lange, reported being 'truly blown away' by recruitment results, noting 4X more patients found than they knew existed, and achieving recruitment goals that were previously unreachable through traditional methods.
• Neuron23coreStrategic or Co-development PartnerWeHealth partnered with Neuron23, a biotech company, to recruit patients for a Phase 2 clinical trial targeting LRRK2 genetic Parkinson's Disease (a rare subset affecting ~3% of PD patients). WeHealth became the trial's #1 highest-converting recruitment channel, matching the sponsor's digital advertising program's enrollment at 10.5X less cost ($74K vs $776K), demonstrating WeHealth's effectiveness for rare disease recruitment.

Scale indicators15 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Antidote: Antidote is a digital patient recruitment platform for clinical trials that matches patients to studies via condition-specific questionnaires and a partner network. It is the most direct functional comparator to WeHealth's patient-led recruitment model, serving the same pharma/biotech sponsor base with a similar B2B recruitment-services motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Customer concentration

• LinkedInlinkedin.com/company/wehealth
• Xx.com/WeHealthNews

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WeHealth